Cargando…

Differences in reporting of adverse drug reactions due to COVID-19 vaccines depending on the reporter

Detalles Bibliográficos
Autores principales:	Pardo-Cabello, Alfredo Jose, Manzano-Gamero, Victoria, Luna, Juan de Dios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Federation of Internal Medicine. Published by Elsevier B.V. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030326/ https://www.ncbi.nlm.nih.gov/pubmed/36966066 http://dx.doi.org/10.1016/j.ejim.2023.03.020

Ejemplares similares

Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2023)

Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2021)

Adverse drug reactions due to ophthalmic drugs: Reporting system in India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2016)

System of adverse drug reactions reporting: What, where, how, and whom to report?
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2015)

Proposal for Publishing and Parallel Reporting of Case Reports on Adverse Drug Reactions to Authorities by Physicians
por: Sickmüller, Barbara, et al.
Publicado: (2013)

Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
por: Jouanjus, Emilie, et al.
Publicado: (2019)

Incident Reporting of Adverse Drug Reaction to Intravenous Ranitidine in an Emergency Department
por: Sud, Saurabh, et al.
Publicado: (2018)

Adverse drug reactions reporting in Turkey and barriers: an urgent need for pharmacovigilance education
por: Khan, Zakir, et al.
Publicado: (2020)

Adverse drug reactions of itolizumab in COVID-19 patient: A case report
por: Mohammed, Ziauddin, et al.
Publicado: (2022)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

Discouraging adverse drug reactions reporting culture: Just a tip of the ‘Gullible Prescribing’
por: Mohammed, Imran
Publicado: (2013)

Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19
por: Bakshi, Satvinder Singh, et al.
Publicado: (2021)

Placebo: a brief updated review
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2022)

Desogestrel and panic attacks – a new suspected adverse drug reaction reported by patients and health care professionals on spontaneous reports
por: Watson, Sarah, et al.
Publicado: (2018)

Adverse drug reaction reporting for more than a decade: The need for pharmacovigilance policy implementation in Turkey
por: Khan, Zakir, et al.
Publicado: (2022)

Adverse drug reaction and causality assessment scales
por: Zaki, Syed Ahmed
Publicado: (2011)

Clinical causality assessment for adverse drug reactions
por: Parida, Satyen
Publicado: (2013)

Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database
por: Campillo, Jeremy T., et al.
Publicado: (2022)

Adverse drug reaction monitoring in psychiatry out-patient
por: Tandon, Vishal
Publicado: (2012)

Adverse drug reactions in the era of multi-morbidity and polypharmacy
por: Birriel, T. Javier, et al.
Publicado: (2015)

A cross-sectional study of adverse drug reactions reporting among doctors of a private medical college in Bihar, India
por: Panja, Buddhadev, et al.
Publicado: (2015)

Rheumatic Immuno-related Adverse Events following Immunotherapy with Checkpoint Inhibitors: Adverse Drug Reaction, or Other?
por: Manzo, Ciro
Publicado: (2021)

Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

Adverse drug reactions with naltrexone: Experience from an addiction treatment center
por: Sarkar, Siddharth, et al.
Publicado: (2021)

Reactive Arthritis Following Vaccination against COVID-19: An Unexpected Adverse Reaction
por: Agrawal, Diksha, et al.
Publicado: (2023)

Adverse reactions to nonsteroidal anti-inflammatory drugs and hypersensitivity to lipid transfer proteins
por: Nucera, Eleonora, et al.
Publicado: (2016)

Reporting inherited kidney diseases: pick up the gauntlet
por: Antón-Gamero, Montserrat, et al.
Publicado: (2021)

Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions-reply
por: Crescioli, Giada, et al.
Publicado: (2021)

Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection
por: Tang, Mi, et al.
Publicado: (2021)

Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection
por: Tang, Mi, et al.
Publicado: (2021)

SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment
por: Figueiredo, J.C., et al.
Publicado: (2022)

Adverse reactions of BNT162b2 vaccine booster against COVID‐19 in Japan
por: Nishizawa, Toshinori, et al.
Publicado: (2022)

Vaccine trials with no serious adverse reactions – estimation of upper 95% confidence intervals for likelihood of such events
por: Grech, Victor, et al.
Publicado: (2022)

Tramadol-Related Adverse Drug Reactions at an Addiction Psychiatry Setting: A Cross-Sectional Analysis
por: Dhagudu, Naveen Kumar, et al.
Publicado: (2019)

Sex Differences in Reported Adverse Drug Reactions to Angiotensin-Converting Enzyme Inhibitors
por: Bots, Sophie H., et al.
Publicado: (2022)

A comparative safety study of reported neurological adverse events with three COVID-19 vaccines
por: Sodhi, Mohit, et al.
Publicado: (2022)

Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data
por: Grandvuillemin, Aurélie, et al.
Publicado: (2020)

Increased Risk of Arrhythmia in COVID-19 Patients: Possible Roles of Both the Disease Pathophysiology and Adverse Drug Reactions
por: Rismanbaf, Ali
Publicado: (2020)

Oxcarbazepine-induced systemic lupus erythematosus: A rare and serious adverse drug reaction to a common anticonvulsant
por: Sinha, Anwita, et al.
Publicado: (2021)

Reporting of adverse drug reactions in clinical trials published in Indian Medical/Dental journals
por: Mody, Purav, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_a08h3umv4r4gfc7smb4bdokc4s